Decisions about add-on reimbursement for medical devices in France in February 2020

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in February 2020.

One (1) decision was released for cardiovascular devices:

• CONFORMABLE GORE TAG, aortic stent (removal from the LPPR list)

One (1) decision was released for orthopaedic devices:

• MAVERICK, lumbar disc prostheses (removal from the LPPR list)

Four (4) decisions were released for other devices:

• ACTIVA SC PATIENT REMOTE CONTROL, remote control (application for modification of registration conditions; clinical benefit is sufficient; absence of added clinical value (V) compared to the comparator)
• THERASPHERE, yttrium-90 microspheres (application for modification of registration conditions; clinical benefit is sufficient for two (2) indications, insufficient for the third; absence of added clinical value (V) for one indication, minor added clinical value (IV) for the second indication compared to the comparator)
• DBLG1 SYSTEM, hybrid closed-loop diabetes management system (application for registration; clinical benefit is sufficient; moderate (III) clinical added value)
• UROLIFT, intraprostatic implant (application for registration; clinical benefit is sufficient; minor (IV) clinical added value compared to the comparator)

See the news in French here.

Visit our online school if you want to learn about French hospital reimbursement system.

Our on-demand 40-minute online seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in France. Additional modules cover reimbursement of IVD tests and screening methods.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.